{"id":294402,"date":"2026-10-08T11:42:03","date_gmt":"2026-10-08T06:12:03","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=294402"},"modified":"2026-10-08T11:42:03","modified_gmt":"2026-10-08T06:12:03","slug":"small-healthcare-and-pharma-stocks-strong-roadmap","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/small-healthcare-and-pharma-stocks-strong-roadmap\/","title":{"rendered":"3 Small Healthcare and Pharma Stocks With a Strong Future Roadmap: Wockhardt, Laxmi Dental and Hester Biosciences"},"content":{"rendered":"

Wockhardt Rs 2,150.40, P\/E 84.33. Laxmi Dental Rs 197.12, P\/E 35.11. Hester Biosciences Rs 2,167.20, P\/E 13.59. Closing prices of 7 Oct 2026.<\/em><\/p>\n

\n

Quick Answer<\/strong><\/p>\n

Small healthcare and pharma stocks with the clearest long-term roadmaps today include Wockhardt in pharma formulations and new antibiotic research, Laxmi Dental in dental aligners and dental products and Hester Biosciences in animal and poultry vaccines and health products. FY26 revenue growth was 13.3% at Wockhardt, 18.1% at Laxmi Dental and 8.6% at Hester Biosciences. P\/E stands at 84.33 for Wockhardt (industry 37.76), 35.11 for Laxmi Dental (industry 62.71) and 13.59 for Hester Biosciences (industry 37.19). Demand cycles, input costs and valuation decide how much of that growth the market keeps paying for, so each company’s risks need equal attention.<\/p>\n<\/p><\/div>\n

Small healthcare and pharma stocks give investors exposure to a turnaround drug maker, a dental products firm and an animal health company. Results depend on product launches, pricing and cost control, which is why margins and cash flow matter as much as headline growth.<\/p>\n

This list covers three turnaround and niche healthcare stocks: Wockhardt for pharma formulations and new antibiotic research, Laxmi Dental for dental aligners and dental products and Hester Biosciences for animal and poultry vaccines and health products. Every figure comes from the latest reported financials and the 7 October 2026 market close. Companies without complete current figures were left out.<\/p>\n

Click Here – Get Free Investment Predictions<\/strong><\/a><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n